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n their article, Kumar et al. (1) demonstrated the
importance of mTORC2 for the insulin-induced glu-
cose transport and lipolysis in adipocytes. They also
discussed the mechanisms of the fat-cell–speciﬁc
deletion of rictor and alterations in the insulin signaling
pathway, leading to systemic insulin resistance. They
suggested that the increased serum nonesteriﬁed fatty acid
levels in FRic
2/2 mice are the mediators for the impair-
ment of the whole-body insulin sensitivity (1). Previously,
Cybulski et al. (2) showed that adipose mTORC2 nega-
tively regulates IGF-1 and insulin production by liver and
pancreas, respectively, and thereby controls systemic
growth and metabolism. These researchers also had
a query for the mTORC2-regulated factor(s) that could be
signaling from adipose tissue to the other insulin sensitive
tissues.
In adipocytes, mTORC2 phosphorylates Akt Serine473,
leading to increased phosphorylation of and inhibition of
AS160, and thereby stimulates the GLUT4 exocytosis (3).
The signaling defects in FRic
2/2 adipocytes impair insulin-
stimulated GLUT translocation to the plasma membrane
and decrease glucose transport (1). On the other hand,
adipocytes, as a glucose sensor, may detect the absence
of glucose uptake by GLUT4 and, in response, secrete
adipokine retinol binding protein (RBP) 4 that impairs
systemic insulin sensitivity (4). RBP4, in turn, may in-
crease the amount of GLUT4 at the plasma membrane and
increase glucose basal uptake (5), suggesting the existence
of a common regulatory pathway for both GLUT4 and
RBP4. Thus, RBP4 might be a mechanistic link by which
downregulation of GLUT4 in FRic
2/2 adipocytes contrib-
ute to the development of systemic insulin resistance. In-
creased release of RBP4 from the FRic
2/2 adipocytes
could be an important mediator of whole-body insulin
sensitivity besides increased nonesteriﬁed fatty acid level.
Thereby, it is tempting to speculate that AS160, under the
control of mTORC2, might be a positive regulator of RBP4
activity in adipocytes. Taken together, evaluation of RBP4
in FRic
2/2 fat cells by the authors could verify the link
between mTORC2 kinase activity and RBP4.
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